Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.

PLoS One · 2013 · PMC3577871 · PMID 23437178

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Th2 specific interleukins, IL-10 and IL-5, correspondingly showed a trend towards increase in the supernatant of the imatinib-treated rats spleenocytes ( Fig. 3 G–H).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.